The Efficacy of Lenvatinib and Everolimus in Chromophobe-type Non-Clear-Cell Renal Cell Carcinoma: A Case Report and Literature Review

被引：3
作者：
Schwartz, Candice [1 ]
Pfanzelter, Nicklas [2 ]
Kuzel, Timothy M. [2 ]
机构：
[1] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Dept Internal Med, Div Hematol Oncol Cell Therapy, Chicago, IL 60612 USA
来源：
CLINICAL GENITOURINARY CANCER | 2017年 / 15卷 / 05期
关键词：
Chromophobe; Everolimus; Lenvatinib; Noneclear-cell renal cell carcinoma; Treatment; OPEN-LABEL; SUNITINIB; MULTICENTER; PHASE-2;
D O I：
10.1016/j.clgc.2017.05.017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
First- and second-line treatments for metastatic none clear-cell renal cell carcinoma (nccRCC) are not extensively studied and based on the well-defined treatments for metastatic clear cell renal cell carcinoma (ccRCC). Lenvatinib and everolimus have been studied in patients with ccRCC and are now established second-line therapy. This case report describes the use of lenvatinib and everolimus in a patient with metastatic nccRCC, and resultant marked reduction in tumor burden. Although it has been studied in patients with ccRCC, additional trials evaluating lenvatinib and everolimus may confirm the efficacy of this treatment regimen in patients with nccRCC.
引用
收藏
页码：E903 / E906
页数：4
相关论文
共 50 条
  • [1] Developing a Clear Path Forward for Non-Clear-Cell Renal Carcinoma
    Pal, Sumanta K.
    Karam, Jose A.
    Bergerot, Paulo
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (32) : 3825 - +
  • [2] Chromophobe renal cell carcinoma in pregnancy: case report and review of the literature
    Mancuso, A
    Macri, A
    Palmara, V
    Scuderi, G
    Grosso, M
    Famulari, C
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2001, 80 (10) : 967 - 969
  • [3] A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma
    Hutson, Thomas E.
    Michaelson, M. Dror
    Kuzel, Timothy M.
    Agarwal, Neeraj
    Molina, Ana M.
    Hsieh, James J.
    Vaishampayan, Ulka N.
    Xie, Ran
    Bapat, Urmi
    Ye, Weifei
    Jain, Rohit K.
    Fishman, Mayer N.
    EUROPEAN UROLOGY, 2021, 80 (02) : 162 - 170
  • [4] Cabozantinib in advanced non-clear-cell renal cell carcinoma: is it the way clearer now?
    Di Pierro, Giulia
    Mini, Enrico
    Roviello, Giandomenico
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [5] Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature
    John, Alexius
    Spain, Lavinia
    Hamid, Anis A.
    CURRENT ONCOLOGY, 2023, 30 (01) : 923 - 937
  • [6] Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study
    Chanza, Nieves Martinez
    Xie, Wanling
    Bilen, Mehrnet Asim
    Dzimitrowicz, Hannah
    Burkart, Jarred
    Geynisman, Daniel M.
    Balakrishnan, Archana
    Bowman, I. Alex
    Jain, Rohit
    Stadler, Walter
    Zakharia, Yousef
    Narayan, Vivek
    Beuselinck, Benoit
    McKay, Rana R.
    Tripathi, Abhishek
    Pachynski, Russell
    Hahn, Andrew W.
    Hsu, JoAnn
    Shah, Sumit A.
    Lam, Elaine T.
    Rose, Tracy L.
    Mega, Anthony E.
    Vogelzang, Nicholas
    Harrison, Michael R.
    Mortazavi, Amir
    Plimack, Elizabeth R.
    Vaishampayan, Ulka
    Hammers, Hans
    George, Saby
    Haas, Naomi
    Agarwal, Neeraj
    Pal, Sumanta K.
    Srinivas, Sandy
    Carneiro, Benedito A.
    Heng, Daniel Y. C.
    Bosse, Dominick
    Choueiri, Toni K.
    Harshman, Lauren C.
    LANCET ONCOLOGY, 2019, 20 (04) : 581 - 590
  • [7] Comprehensive review of chromophobe renal cell carcinoma
    Garje, Rohan
    Elhag, Dean
    Yasin, Hesham A.
    Acharya, Luna
    Vaena, Daniel
    Dahmoush, Laila
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 160
  • [8] Efficacy and toxicity of sunitinib for non clear cell renal cell carcinoma (RCC): A systematic review of the literature
    Abdel-Rahman, Omar
    Fouad, Mona
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (02) : 238 - 250
  • [9] Hypertension Caused by Lenvatinib and Everolimus in the Treatment of Metastatic Renal Cell Carcinoma
    Bendtsen, Mathias Alro Fichtner
    Grimm, Daniela
    Bauer, Johann
    Wehland, Markus
    Wise, Petra
    Magnusson, Nils E.
    Infanger, Manfred
    Krueger, Marcus
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (08)
  • [10] Chromophobe Renal Cell Carcinoma Presenting as a Cystic Renal Mass: Case Report and Review of the Literature
    AlGhamdi, Maram H.
    AlShabyli, Nayef A.
    Alayed, Abdullah
    AMERICAN JOURNAL OF CASE REPORTS, 2019, 20 : 631 - 634
12345